Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Any sex/gender of any ethnic/racial background
• Age greater than or equal to 18 years
• Histologically confirmed rectal cancer stage II, III, or IV (if curative) per AJCC criteria
• Histologically confirmed HER2+ or triple negative breast cancer stage I, II, III, or IV (only if definitive intent) per AJCC criteria
• BMI 18.5 kg/m2 or greater
• Will receive neoadjuvant therapy
• Has completed ≤ 4 weeks of neoadjuvant treatment prior to study enrollment
• Willing and able to adhere to the assessments, visit schedules, prohibitions, and restrictions
Locations
United States
California
Cedars-Sinai Medical Center
RECRUITING
West Hollywood
Contact Information
Primary
Nathalie Nguyen, MPH
nathalie.nguyen@cshs.org
310.423.4209
Time Frame
Start Date: 2022-01-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 175
Treatments
Experimental: Time-Restricted Eating (TRE)
8-hour daily eating period, starting 1-3 hours after waking up
Active_comparator: Control
More than equal to a 12-hour daily eating period
Related Therapeutic Areas
Sponsors
Collaborators: University of Alabama at Birmingham, National Cancer Institute (NCI)
Leads: Cedars-Sinai Medical Center